Authors' reply to Mark Jones's second critique of the study by Muthuri and colleagues reported in The BMJ

BMJ. 2014 Apr 30:348:g3004. doi: 10.1136/bmj.g3004.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Enzyme Inhibitors / therapeutic use*
  • Female
  • Humans
  • Influenza A Virus, H1N1 Subtype*
  • Influenza, Human / drug therapy*
  • Male
  • Neuraminidase / antagonists & inhibitors*
  • Oseltamivir / therapeutic use*
  • Pandemics*
  • Zanamivir / therapeutic use*

Substances

  • Antiviral Agents
  • Enzyme Inhibitors
  • Oseltamivir
  • Neuraminidase
  • Zanamivir